- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05983692
Mg Wire for Augmentation of ACL Reconstruction
Clinical Translation of Biodegradable Magnesium Wire for Augmentation of Anterior Cruciate Ligament (ACL) Reconstruction From Bench Side to Bedside: A Multicentre, Double-blinded, Randomised Controlled Trial
Background: ACLR with autologous tendon graft is commonly used for the treatment of ACL injury. However, as the BTI healing is poor, this can lead to a failure rate of 5% in the first-year post-operation; a long and unpredictable rehabilitation period is expected and 35 % of patients never return to preinjury level of sports. Biological enhancement of BTI healing will help to cut down the medical cost related to poor prognosis. As a biodegradable metal, Mg has been developed as implants in orthopaedics for decades, yet without clinical implants developed for ACLR. Our team has been working on this area in the past 10 years preclinically. Our animal studies showed that supplementation of magnesium wire significantly promotes osteogenesis at BTI and improves mechanical strength in ACLR. Recently, our team developed a highly pure (99.99%) Mg wire (Fig 2) in collaboration with metallic engineers for tendon graft braiding during ACLR and with its improved physical quality and strength, it is suitable for graft braiding and then its degradation in vivo can promote tunnel bone formation and bone tendon interface integration.
Objective: To investigate if anterior cruciate ligament (ACL) reconstruction augmented with magnesium (Mg) wire enhances osteogenesis at the bone-tendon interface (BTI), improving post-op rehabilitation and leading to better clinical outcomes.
Hypothesis: Patients with ACL reconstruction using Mg wire will experience improved osteogenesis at the BTI, more effective rehabilitation, and superior knee strength and function.
Design and Subjects: A multicentre, double-blinded, randomized controlled trial will recruit patients aged 18-30 with unilateral ACL tear for primary ACLR with a hamstring graft at four sites.
Instruments: Mg-based wire.
Interventions: Participants will receive either 99.99% purity Mg wire or 2-0 vicryl as a control.
Main Outcomes: Osteogenesis will be assessed by High-Resolution Peripheral Quantitative Computed Tomography (HR-pQCT), muscle strength via Biodex tests, and functional recovery with International Knee Documentation Committee (IKDC) and Tegner scores at multiple post-op intervals. Knee stability will be checked with KT-1000 arthrometer. Blood samples will be analyzed for inflammatory markers and metabolic effects related to Mg wire.
Data Analysis and Expected Results: A repeated-measures ANOVA will be utilized for data analysis. The expectation is that Mg wire augmentation will significantly enhance osteogenesis at the BTI and improve rehabilitation outcomes.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Michael Tim-Yun Ong
- Phone Number: 055699059
- Email: michael.ong@cuhk.edu.hk
Study Locations
-
-
-
Hong Kong, Hong Kong
- The Chinese University of Hong Kong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18-40
- Unilateral ACL tear for primary ACLR (Single bundle, Hamstring) confirmed clinically and radiologically.
Exclusion Criteria:
- Concomitant multiple ligament injuries requiring additional surgical procedures,
- Preoperative radiographic signs of arthritis,
- Revision ACLR
- Femoral tunnel interference screws
- Contralateral knee with ACL deficiency or reconstruction
- Medical co-morbidities
- Long-term steroid intake
- Non-compliance to our rehabilitation protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Mg Wire group
Intervention: Magnesium-based wire as braiding suture to braid the tendon graft.
|
Mg wire will be used as a braiding suture to braid tendon graft, which is a standard preparation of graft and is not related to fixation of the tendon graft
|
No Intervention: control group
2-0 vicryl suture as control, size and length matched Mg wire
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bone shell size
Time Frame: 2 weeks and 3, 6, 12 and 24 months post-operation.
|
HR-pQCT (ExtremCT II, Scanco, Switzerland) will be used to measure the bone shell size at graft tunnel interface.
The involved knees will be investigated.
A total of 1344 axial slices with an image matrix of 2304 × 2304 were collected at a nominal isotropic voxel size of 60.7μm.
The scan region was defined by the scout view image acquired in the sagittal plane.The total scanning length was 81.6mm which covered the tunnel from proximal tibia to distal femoral condyle (X-ray settings: 68kVp, 1470μA, 100ms integration time, 156mAs per stack (168 slices).Image segmentation will be performed to select the bone shell features at graft tunnel interfaces near femoral and tibial intra-articular apertures with standardized threshold values at a thickness of ~2.5 mm (40 slices).
Geometric transformation will be performed to adjust for the variations in angle between scanning axis and tunnel axis by a cosine function.
|
2 weeks and 3, 6, 12 and 24 months post-operation.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
International Knee Documentation Committee
Time Frame: Pre-operation, 2 weeks and 3, 6, 12 and 24 months post-operation.
|
Consists of 10 questions on symptoms and activity ranging from 0 to 100 where 100 implies perfect knee function.
|
Pre-operation, 2 weeks and 3, 6, 12 and 24 months post-operation.
|
Tegner activity score
Time Frame: Pre-operation, 2 weeks and 3, 6, 12 and 24 months post-operation.
|
This is an activity level scaled from 1 (low activity) to 10 (high activity).
|
Pre-operation, 2 weeks and 3, 6, 12 and 24 months post-operation.
|
Passive Knee laxity
Time Frame: 3, 6, 12 and 24 months post-operation.
|
To measure anterior-posterior knee laxity, the KT-1000 knee ligament arthrometer (MEDmetric Corp, San Diego, CA, USA) will be used.
A manual force test will be applied until a 30lb sound signal is activated.
Three trials will be performed.
A side difference of 3 mm above is considered clinically relevant.
|
3, 6, 12 and 24 months post-operation.
|
Isokinetic muscle strength
Time Frame: 3, 6, 12 and 24 months post-operation
|
The dynamometer (Biodex System 4, Biodex Medical Systems Inc., New York, USA) will be used for measuring Isokinetic muscle strength in N. Subjects will perform a standardized warm-up exercise (5 min cycling) followed by the test.
Concentric/concentric contractions of knee extension/flexion will be tested at 60°/s and 180°/s.
Subjects will be seated on the dynamometer chair with their hips flexed to 85°.
|
3, 6, 12 and 24 months post-operation
|
Single leg hop distance
Time Frame: 6, 12 and 24 months post-operation
|
The average of single leg hop distance in cm with three attempts will be measured during the single leg hop test.
|
6, 12 and 24 months post-operation
|
Cytokines assay
Time Frame: Pre-operation, Day 1, 2 and 6 weeks and 3 months post-operation
|
To evaluate the safety of Mg wire with respect to inflammatory responses, 5 ml blood samples will be collected for C-reactive protein measurement using ELISA kit. Measurements of Ca, Mg, P, Cr, Urea, ALT, AST, TP, ALB, GLB will be taken to monitorpotential effect of the Mg wire. The blood tests will be performed at baseline, day 1 post-op, 2 weeks, 6 weeks and 12 weeks post-op, since the degradation of Mg wire is faster based on our preclinical study results. |
Pre-operation, Day 1, 2 and 6 weeks and 3 months post-operation
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021.654
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anterior Cruciate Ligament Rupture
-
Bezirkskrankenhaus SchwazNot yet recruitingAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Reconstruction | Anterior Cruciate Ligament InjuryAustria
-
University of Colorado, DenverChildren's Hospital ColoradoRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited States
-
Karolinska InstitutetRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearSweden
-
Rush University Medical CenterEnrolling by invitationAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament InjuryUnited States
-
Bahçeşehir UniversityIstanbul University - Cerrahpasa (IUC)CompletedAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearTurkey
-
Miach OrthopaedicsActive, not recruitingAnterior Cruciate Ligament Rupture | Anterior Cruciate Ligament InjuryUnited States
-
University of BathVersus ArthritisRecruitingPost-traumatic Osteoarthritis | Anterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament Tear | Anterior Cruciate Ligament ReconstructionUnited Kingdom
-
Artromedical Konrad Malinowski ClinicRecruitingAnalysis of Radiological Features of Lateral Femoral Impaction Fracture / Lateral Femoral Notch SignAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearPoland
-
Artromedical Konrad Malinowski ClinicRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearPoland
-
Liverpool University Hospitals NHS Foundation TrustRecruitingAnterior Cruciate Ligament Injuries | Anterior Cruciate Ligament Rupture | Anterior Cruciate Ligament TearUnited Kingdom
Clinical Trials on Magnesium based wire
-
Xuanwu Hospital, BeijingNational Key Research and Development Project, ChinaCompletedStroke, Ischemic | Intracranial AtherosclerosisChina
-
Beijing Anzhen HospitalCompletedMyocardial Ischemia | Coronary Artery Disease | Myocardial Fractional Flow ReserveChina
-
Jonsson Comprehensive Cancer CenterCompletedHealth Status UnknownUnited States
-
University Hospital Southampton NHS Foundation...CompletedCoronary Artery DiseaseUnited Kingdom, Ireland
-
Lawson Health Research InstituteTerminatedSmall Bowel DiseasesCanada
-
Ge JunboRainMed MedicalCompleted
-
Cairo UniversityCompleted
-
Assiut UniversityCompleted
-
Medical University of ViennaCompletedChronic Total Coronary Occlusion
-
The Second Hospital of QinhuangdaoCompletedBony Mallet FingerChina